Variants of estrogen-related genes and breast cancer risk in European and African American women

Compared to women of European ancestry (EA), those of African ancestry (AA) are more likely to develop estrogen receptor (ER) negative breast cancer, although the mechanisms have not been elucidated. We tested the associations between breast cancer risk and a targeted set of 20 genes known to be involved in estrogen synthesis, metabolism and response and potential gene-environment interactions using data and samples from 1307 EA (658 cases) and 1365 AA (621 cases) participants from the Women’s Circle of Health Study (WCHS). Multivariable logistic regression found evidence of associations with single nucleotide polymorphisms (SNPs) in the ESR1 gene in EA women (rs1801132, OR=1.47, 95%CI=1.20–1.80, p=0.0002; rs2046210, OR=1.24, 95%CI=1.04–1.47, p=0.02; and rs3020314, OR=1.43, 95%CI=1.19–1.70, p=0.00009); but not in AA women. The only other gene associated with breast cancer risk was CYP1A2 in AA women (rs2470893, OR=1.42, 95%CI=1.00–2.02, p=0.05), but not in EA women. When stratified by ER status, ESR1 rs1801132, rs2046210 and rs3020314 showed stronger associations in ER positive than in ER negative breast cancer in only EA women. Associations with the ESR1 SNPs in EA women also appeared to be stronger with longer endogenous estrogen exposure or hormonal replacement therapy (HRT) use. Our results indicate that there may be differential genetic influences on breast cancer risk in EA compared to AA women and these differences may be modified by tumor subtype and estrogen exposures. Future studies with a larger sample size may determine the full contribution of estrogen-related genes to racial/ethnic differences of breast cancer.